Biora Therapeutics to Participate in Upcoming H.C. Wainwright Investment Conference
SAN DIEGO, Sept. 06, 2022 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq:BIOR), the biotech company that is reimagining therapeutics, today announced that the company’s management team will be presenting and participating in one-on-one meetings at the H.C. Wainwright 24th Annual Global Investment Conference, which is taking place both virtually and at the Lotte New York Palace Hotel in New York City, September 12-14, 2022.
Related news for (BIOR)
- biora therapeutics announces $3 million registered direct offering priced at-the-market under nasdaq rules
- biora therapeutics shares progress on smaller biojet™ clinical device with largest payload of any ingestible injectable at the 14th annual podd meeting
- biora therapeutics to reveal 00-size biojet™ device at the 14th annual partnership opportunities in drug delivery meeting
- biora therapeutics to present at the 19th annual peptide therapeutics symposium
- biora therapeutics announces award-winning abstract to be presented at american college of gastroenterology annual scientific meeting 2024